La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MedAdvisor Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Rick Ratliff

Amministratore delegato

AU$2.0m

Compenso totale

Percentuale dello stipendio del CEO	33.4%
Mandato del CEO	2.1yrs
Proprietà del CEO	n/a
Durata media del management	1.8yrs
Durata media del Consiglio di amministrazione	2.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Nov 09

Is MedAdvisor (ASX:MDR) A Risky Investment?

Oct 11

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Mar 08

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

Feb 10

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

Jan 18

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

Dec 22

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Dec 18

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Nov 22

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Rick Ratliff rispetto agli utili di MedAdvisor?
Data	Compenso totale	Stipendio	Guadagni aziendali
Dec 31 2023	n/a	n/a	-AU$9m
Sep 30 2023	n/a	n/a	-AU$10m
Jun 30 2023	AU$2m	AU$678k	-AU$11m

Compensazione vs Mercato: La retribuzione totale di Rick ($USD 1.37M ) è superiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 650.58K ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Rick con le performance aziendali.

AMMINISTRATORE DELEGATO

Rick Ratliff

2.1yrs

Mandato

AU$2,030,589

Compensazione

Mr. Richard Ratliff, also known as Rick, MBA IT, BChE serves as Chief Executive Officer & Managing Director and Director at MedAdvisor Limited since July 15, 2022. He serves as Chief Commercial Officer at...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Richard Ratliff	CEO, MD & Director	2.1yrs	AU$2.03m	Nessun dato
Ancila Desai	CFO & Joint Company Secretary	1.8yrs	AU$461.20k	Nessun dato
Craig Schnuriger	Acting Chief Technology Officer	4.4yrs	Nessun dato	Nessun dato
James Rotsart	Executive VP of US & Client Relations	no data	Nessun dato	Nessun dato
Wayne Marinoff	President of ANZ	1.6yrs	Nessun dato	Nessun dato
Anshu Raghuvanshi	Joint Company Secretary	1.4yrs	Nessun dato	Nessun dato

1.8yrs

Durata media

Gestione esperta: Il team dirigenziale di MDR non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Richard Ratliff	CEO, MD & Director	2.1yrs	AU$2.03m	Nessun dato
Linda Jenkinson	Independent Non-Executive Chairman	2.5yrs	AU$373.08k	Nessun dato
Kevin Hutchinson	Independent Non-Executive Director	1.8yrs	AU$102.62k	0.11% A$ 267.4k
Lucas Merrow	Independent Non-Executive Director	3yrs	AU$94.10k	0.17% A$ 427.8k
Sandra Hook	Independent Non-Executive Director	8.6yrs	AU$130.78k	0.056% A$ 140.8k
Arthur Charlaftis	Member of Advisory Board	8.4yrs	Nessun dato	Nessun dato
Jim Xenos	Non-Executive Director	8.8yrs	AU$84.58k	1.25% A$ 3.1m
Mike Da Gama	Member of Advisory Board	8.4yrs	AU$25.89k	Nessun dato
Nick England	Member of Advisory Board	8.4yrs	Nessun dato	Nessun dato
Catherine Hill	Independent Non-Executive Director	1.3yrs	AU$5.78k	Nessun dato
Anthony Tassone	Non-Executive Director	2.1yrs	Nessun dato	Nessun dato
Brett Magun	Non-Executive Director	1.3yrs	Nessun dato	Nessun dato

2.8yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di MDR non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.

MedAdvisor Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited Announces Board Changes

Recent updates

Forecast breakeven date pushed back to 2025

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Price target increased by 13% to AU$0.51

Consensus EPS estimates upgraded to AU$0.0033 loss

Forecast breakeven date moved forward to 2025

Consensus EPS estimates fall by 11%, revenue upgraded

Why Investors Shouldn't Be Surprised By MedAdvisor Limited's (ASX:MDR) Low P/S

Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?

Forecast breakeven date pushed back to 2026

New minor risk - Profitability

Now 24% overvalued after recent price rise

Consensus estimates of losses per share improve by 33%

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

Consensus estimates of losses per share improve by 32%

Full year 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 50%

MedAdvisor Limited Announces Board Changes

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Consensus EPS estimates fall by 80%, revenue upgraded

First half 2023 earnings released: EPS: AU$0.009 (vs AU$0.02 loss in 1H 2022)

Price target increased to AU$0.40

MedAdvisor Limited Provides Revenue Guidance for the First Half of the Fiscal Year 2023

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited to Report Q1, 2023 Results on Oct 28, 2022

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited, Annual General Meeting, Nov 30, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

MedAdvisor Limited (ASX:MDR) entered a binding agreement to acquire GuildLink Pty Ltd from Guild Group Holdings Limited for AUD 8 million.

MedAdvisor Limited Announces Executive Changes

MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

MedAdvisor Limited Announces Change of Managing Director

Price target decreased to AU$0.40

No longer forecast to breakeven

Less than half of directors are independent

MedAdvisor Limited Announces Retirement of Robert Read as CEO

Consensus forecasts updated

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited to Report First Half, 2022 Results on Feb 25, 2022

MedAdvisor Limited Appoints Raeann Grossman to the Board as A Non-Executive Director

Independent Non-Executive Director Peter Bennetto has left the company

Non-Executive Director recently sold AU$2.5m worth of stock

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Is MedAdvisor (ASX:MDR) A Risky Investment?

Less than half of directors are independent

Full year 2021 earnings released

Non-Executive Director has left the company

MedAdvisor Limited announced that it has received AUD 5.25 million in funding

New 90-day low: AU$0.34

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

First half 2021 earnings released: AU$0.029 loss per share (vs AU$0.024 loss in 1H 2020)

MedAdvisor Limited to Report First Half, 2021 Results on Feb 25, 2021

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

New 90-day low: AU$0.34

Non-Executive Chairman of the Board recently bought AU$70k worth of stock

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

MedAdvisor Limited Signs an Additional One-Year Deal with A Major Global Pharmaceutical Company

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

New 90-day low: AU$0.36

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

New 90-day low: AU$0.39

MedAdvisor Limited Extends Health Programs in the US

New 90-day low: AU$0.41

MedAdvisor Limited Launches ePrescribing across Australia

New 90-day low - AU$0.44

Full year earnings released